# Arcturus Therapeutics

> mRNA, RNA medicines company

Business model and tags: B2B

## About Arcturus Therapeutics

Develops messenger RNA medicines for liver and respiratory rare diseases, utilizing LUNAR® delivery, STARR® mRNA technology, and manufacturing expertise for various RNA therapeutics.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 51–250 employees
- **Headquarters**: San Diego, California, United States
- **Founded**: 2013
- **Revenue**: $82M (FY2025, publicly reported)
- **Website**: [arcturusrx.com](arcturusrx.com)
- **LinkedIn**: [linkedin.com/company/arcturus-therapeutics](https://www.linkedin.com/company/arcturus-therapeutics)

## Arcturus Therapeutics at a glance

Arcturus Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in San Diego, California, United States.

Arcturus Therapeutics was founded in 2013.

Arcturus Therapeutics has 51–250 employees.

Arcturus Therapeutics's revenue is $82M (FY2025, publicly reported).

## Frequently asked questions about Arcturus Therapeutics

### What is Arcturus Therapeutics's revenue?

Arcturus Therapeutics's revenue is $82M (FY2025, publicly reported).

### How many employees does Arcturus Therapeutics have?

Arcturus Therapeutics has 51–250 employees.

### Where is Arcturus Therapeutics headquartered?

Arcturus Therapeutics is headquartered in San Diego, California, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/arcturus-therapeutics
